文献速递慢阻肺

欧洲人群出生年份相关的肺功能变化及其对肺疾病诊断的影响

Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease: a cross-sectional analysis of ten population-based studies.
PubMed 文献 · Lancet Respir Med · 2021-10-04

作者认为若现行诊断标准不变,欧洲人群肺功能值的这种漂移将使慢阻肺等疾病的诊断标准更易满足,但会系统性低估疾病严重程度。

要点

  • FEV1和FVC随出生年份增加,且独立于身高变化。
  • FEV1/FVC比值随出生年份显著下降。
  • 现行诊断标准下可能更易诊断慢阻肺但低估严重程度。

核心结论

  • 欧洲人群FEV1和FVC随出生年份增加,FEV1/FVC比值下降,可能影响肺疾病诊断。
  • 若诊断标准不变,将更易满足慢阻肺诊断标准,但会系统性低估疾病严重程度。

研究设计与样本

  • 十项欧洲人群研究的横断面分析,纳入20-94岁、出生于1884-1996年的个体。
  • 使用meta回归分析FEV1、FVC及FEV1/FVC比值随出生年份的变化,并调整年龄、研究、身高、性别、吸烟状态、吸烟包年及体重等变量。

主要发现

  • 32个已发表的参考方程预测的FEV1和FVC值随估计出生年份的变化与上述结果一致。

临床怎么用

  • 临床解读肺功能时应考虑出生年份队列效应,避免因人群肺功能值漂移而误判。
  • 现行诊断标准可能导致慢阻肺过度诊断或严重程度低估,需结合临床综合评估。

局限性

  • 研究为横断面设计,无法确立因果关系。
  • 仅纳入欧洲人群,结果外推需谨慎。
  • 未报告其他潜在混杂因素的调整情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During the past century, socioeconomic and scientific advances have resulted in changes in the health and physique of European populations. Accompanying improvements in lung function, if unrecognised, could result in the misclassification of lung function measurements and misdiagnosis of lung diseases. We therefore investigated changes in population lung function with birth year across the past century, accounting for increasing population height, and examined how such changes might influence the interpretation of lung function measurements. METHODS: In our analyses of cross-sectional data from ten European population-based studies, we included individuals aged 20-94 years who were born between 1884 and 1996, regardless of previous respiratory diagnoses or symptoms. FEV1, forced vital capacity (FVC), height, weight, and smoking behaviour were measured between 1965 and 2016. We used meta-regression to investigate how FEV1 and FVC (adjusting for age, study, height, sex, smoking status, smoking pack-years, and weight) and the FEV1/FVC ratio (adjusting for age, study, sex, and smoking status) changed with birth year. Using estimates from these models, we graphically explored how mean lung function values would be expected to progressively deviate from predicted values. To substantiate our findings, we used linear regression to investigate how the FEV1 and FVC values predicted by 32 reference equations published between 1961 and 2015 changed with estimated birth year. FINDINGS: Across the ten included studies, we included 243 465 European participants (mean age 51·4 years, 95% CI 51·4-51·5) in our analysis, of whom 136 275 (56·0%) were female and 107 190 (44·0%) were male. After full adjustment, FEV1 increased by 4·8 mL/birth year (95% CI 2·6-7·0; p<0·0001) and FVC increased by 8·8 mL/birth year (5·7-12·0; p<0·0001). Birth year-related increases in the FEV1 and FVC values predicted by published reference equations corroborated these findings. This height-independent increase in FEV1 and FVC across the last century will have caused mean population values to progressively exceed previously predicted values. However, the population mean adjusted FEV1/FVC ratio decreased by 0·11 per 100 birth years (95% CI 0·09-0·14; p<0·0001). INTERPRETATION: If current diagnostic criteria remain unchanged, the identified shifts in European values will allow the easier fulfilment of diagnostic criteria for lung diseases such as chronic obstructive pulmonary disease, but the systematic underestimation of lung disease severity. FUNDING: The European Respiratory Society, AstraZeneca, Chiesi Farmaceutici, GlaxoSmithKline, Menarini, and Sanofi-Genzyme.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Allinson JP, Afzal S, Çolak Y, et al. Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease: a cross-sectional analysis of ten population-based studies. Lancet Respir Med. 2021. PMID: 34619103. doi:10.1016/S2213-2600(21)00313-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。